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THE PROGNOSTIC VALUE OF MATERNAL RH·ANTIBODY INHIBITION STUDIES AND
LIQUOR AMNII INVESTIGATIONS*
G. H. Vas, t Department of Pathology, King Edward Memorial Hospital tor Women, Subiaco, Western Australia
As a guide to the management of pregnancies complicated
by Rh immunization, considerable progress was made with
the introduction of amniotic fluid studies pioneered by
Bevis,],2 and many investigators have now confirmed the
relationship of bile pigment concentration in the amniotic
fluid to the intensity of Rh-haemolytic disease in utero.
However, in spite of such advances the spectrophoto-
metric,' chemical' and pigment-protein ratio procedures'
cannot always be accepted as being infallible, their short-
comings being too seldom emphasized while their advan-
tages are simply taken for granted.'
Some investigators'" believe that with the introduction
of liquor amnii studies nothing useful can be gained by
the inclusion of maternal Rh-antibody investigations.
Others""]] emphasize that the prediction of the severity of
Rh-haemolytic disease by amniotic fluid analysis can at
times be most misleading. Thus, fully endorsed cautions
about relying on the predictions obtained by amniotic
fluid studies alone have led investigators to believe that
bile pigment levels should be used only in conjunction
with maternal Rh-antibody estimations."''''
Since repeated abdominal paracentesis on every Rh-im-
munized mother can result in errors in the antenatal pre-
diction of the severity of the disease",H-" selective amnio-
centesis has become an acceptable practice. The recording
of low maternal Rh-antibody values is really not indica-
tive of severe haemolytic manifestations of the disease.
In this report an analysis is presented which is intended
to show that the application of Rh-antibody inhibition
studies· can introduce a real measure of prognostic re-
liability in predicting the severity of Rh-haemolytic di-
sease, particularly when the significance of liquor amnii
values appears to be in some doubt. The routine use of
maternal antibody studies is therefore designed as an
effective procedure for supplementing the values obtained
by spectrophotometric analysis. Rh-antibody studies can,
in fact, be looked upon as a test to reveal whether a
clinically favourable forecast of severity obtained by
liquor examinations at 26 - 30 weeks of gestation continues
to be the same at 34 weeks' gestation, especially when we
take into account that more frequent episodes of re-
immunization can be anticipated after 30 weeks of
pregnancy."
MATERIALS AND METHODS
All Rh-immunized mothers examined in this study were
seen from the first trimester of pregnancy onwards.
Mothers in whom the production of Rh antibodies may
have been the result of previous Rh-incompatible blood
transfusions were excluded; and only Rh-incompatible
mother-infant combinations were used.
For the evaluation of the Rh-antibody inhibition index
the procedure detailed in a previous communication· was
used. Rh-antibody titre values were determined by the
standardized method of indirect antiglobulin titration."
*Paper presented at the National Blood Transfusion Congress held in
Durban, July 1967.
tPresent address: Natal Institute of Immunology, Durban.
Amniotic Fluid Studies
Amniotic fluid obtained by abdominal paracentesis was
centrifuged immediately after collection at 4,000 r.p.m.
for 30 minutes to remove cellular elements and was then
placed in a light-proof container if an immediate analysis
was not performed. Analysis of bile pigment concentra-
tions in the specimen was carried out using the spectro-
photometric procedure described by Fleming and Woolf,'9
while the total protein value was determined by the biuret
reaction as described by Morris et al.' The calculation of
pigment-protein ratio employed herein was also carried
out as recommended by the same authors. Serum bilirubin
estimations on the infants' cord bloods were determined
by the method of Powell.''O
RESULTS AND DISCUSSION
To present an objective analysis between the efficiency of
amniotic fluid measurements and Rh-antibody inhibition
studies, an investigation was carried out on 66 Rh-im-
munized mothers who had delivered Rh-incompatible in-
fants. In the assessment of how closely these 2 procedures
.can forecast the severity of foetal red cell destruction in
utero, it is important to realize that the Rh-antibody inhi-
bition test determines the measured intensity of antibody
implication up to the time of delivery. On the other hand,
amniotic fluid studies (particularly when performed before
30 weeks of pregnancy) can only be considered to have
measured the intensity of foetal red cell haemolysis known
to be present at the time the amniotic fluid sample was
obtained.
In order to reduce variations of this nature to a mini-
mum it was important to use only the highest projected
spectrophotometric measurement obtained from a series
of amniotic studies on the same patient. It should also be
noted that an average of 2-4 amniotic fluid samples were
tested from the 66 mothers examined. Their time of col-
lection ranged from 28 to 33 weeks of gestation and in no
instance were single amniotic fluid studies included if they
were performed after 33 weeks of pregnancy. A detailed
analysis of the serological, biochemical and haematologi-
cal findings of the 66 Rh-immunized mothers and their
infants is given in Table 1.
To determine how closely the Rh-antibody inhibition
index and bilirubin protein values are related to the severity
of the infant's anaemia at birth, a biserial r correlation
coefficient analysis was carried out for the 2 testing pro-
cedures against (a) the haemoglobin concentration of the
infant's cord blood at birth, (b) total serum bilirubin
value observed at birth, and (c) the severity of Rh-haemo-
lytic disease as determined by the infant's clinical condi-
tion. Table IT sets out the results of this analysis and from
the information obtained it can be seen that both pro-
cedures (amniotic fluid values and antibody inhibition
studies) accurately predicted that an infant's cord-blood
haemoglobin levels will be low when the bilirubin/pro-
tein ratio or Rh-antibody inhibition index values are
high.
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TABLE I. SEROLOGY, BIOCHEMISTRY A D HAEMATOLOGY OF 66 RH-IMMU '[ZED MOTHERS WHO DELIVERED RH-POSITIVE I FANTS
Liquor amnii studies
Maternal Cord-blood estimations
Case Rh-antibody Ratio Time of delivery, Clinical el'aluation
No. inhibition Bilirubin Protein bilirubin Haemoglobin Bilirubin trearment, and of rhe diseaset
index at fLg"./ml. mg./ml_ fLg-/mg- of G/100 ml_ total mg_/100 ml_ outcome*
delivery protein
1 450 2·5 6-4 0-39 11-8 5·4 35/52, Ex_ Tr. A & W 2
2 560 3-2 3-6 0-89 Stillborn 28/52 4
3 640 12-4 6-8 1-82 Stillborn 30/52 4
4 204 1-4 5-2 0-26 16·2 2-2 36/52, A & W I
5 620 10·7 6-7 I-56 Stillborn 35/52 4
6 570 1-9 6-3 0-31 6-4 8-6 36/52, Ex_ Tr. A & W 3
7 312 2-3 5-7 0·40 11-6 3-7 35/52, Ex_ Tr. A & W 3
8 36 1- 1 5-4 0-20 12·3 3-3 36/52, A & W I
9 144 1-2 3-8 0·31 12·0 3·0 36/52, Ex_ Tr. A & W 2
10 896 6-2 4-9 1-26 Stillborn 31/52 4
11 206 2·9 7-1 0-40 10-8 4-8 35/52, Ex_ Tr. A & W 2
12 428 1-4 3-4 0·44 9-4 3 - I 36/52, Ex_ Tr. A & W 3
13 68 1-2 5-8 0-20 13 -6 3-4 36/52, Ex. Tr. A & W I
14 560 1-9 3-1 0-61 10-2 2-5 35/52, Ex_ Tr. A & W 2
15 488 2-4 3-8 0-63 6·8 5-2 35/52, Ex_ Tr. A & W 3
16 1,120 3-9 6-2 0·63 8·0 5-7 35/52, Ex_ Tr. A & W 3
17 10 1-I 3-8 0-28 17·8 2-1 40/52, A & W 1
18 72 0·8 2-8 0-28 13 -3 3-1 38/52, A & W I
19 24 0-6 2-9 0-20 15 ·0 3-3 40/52, A & W 1
20 180 3-3 5-0 0-66 10·3 3-9 38/52, Ex. Tr. A & W 2
21 280 1·0 2-7 0-37 9-3 2-6 36/52, Ex. Tr. A & W 3
22 320 2-0 2-8 0-71 10-7 3-8 35/52, Ex. Tr. A & W 2
23 700 12-0 7-0 1·70 Stillborn 31/52 4
24 220 1·6 5-4 0·29 15 -I 2-4 37/52, Ex_ Tr. A & W I
25 800 2-0 5·8 0-34 5 ·1 7·2 36/52, Ex_ Tr. A & W 3
26 350 2-6 6·1 0·42 10·8 2-9 36/52, Ex_ Tr. A & W 3
27 54 1-3 6·3 0·20 13-8 2·7 36/52, A & W I
28 400 2-2 5·8 0·37 11-0 5-0 36/52, Ex_ Tr. A & W 2
29 600 3-0 3-4 0·88 Stillborn 30/52 4
30 820 8-4 7-3 1·15 Stillborn 29/52 4
31 840 9-7 7·2 1-34 Stillborn 34/52 4
32 150 1-5 4-8 0-31 13-4 2-6 37/52, Ex_ Tr. A & W 2
33 230 2-4 5-4 0·44 11-7 4-3 36/52, Ex_ Tr. A & W 2
34 454 1-6 3·8 0·42 9·1 3-7 36/52, Ex_ Tr. A & W 3
35 80 0-9 4-2 0-21 14-0 2-7 37/52, Ex_ Tr. A & W 1
36 540 2-0 3 ·1 0-64 11·9 2-9 36/52, Ex_ Tr. A & W 3
37 522 2-8 4·2 0-66 7·0 5·6 35/52, Ex_ Tr. A & W 3
38 980 4-2 5·8 0·72 6-7 5-0 35/52, Ex_ Tr. A & W 3
39 26 1-7 7·3 0-23 15·4 2-1 38/52, A & W I
40 92 0-5 2-4 0-20 14-3 2-4 39/52, A & W 1
41 78 0-9 4·3 0-21 13·9 3-1 40/52, A & W I
42 200 4·1 6·8 0·60 12·0 4-8 37/52, Ex_ Tr. A & W 2
43 310 1-5 4·4 0-34 10-1 3-7 36/52, Ex_ Tr. A & W 2
44 420 1-9 2-4 0·79 9·4 3-9 35/52, Ex. Tr. A & W 3
45 640 3-4 3-8 0-89 Stillborn, 29/52 4
46 500 2-8 6-6 0-42 12·0 6-1 36/52, Ex. Tr. A & W 2
47 180 1-2 5-8 0·20 14·3 2·7 36/52, Ex_ Tr. A & W I
48 620 2-3 5·2 0-44 8-7 4·8 35/52, Ex_ Tr. A & W 3
49 300 1·8 4-1 0-43 12-1 3-9 36/52, Ex. Tr. A & W 2
50 68 1-4 6·1 0-26 14-2 2·4 36/52, A & W 1
51 96 1·0 3-3 0-30 15-1 2-7 37/52, A & W I
52 190 2-0 5·2 0-38 11-7 3-9 36/52, Ex_ Tr. A & W 2
53 720 11·4 6-5 1·75 Stillborn, 30/52 4
54 400 1 -3 4·1 0-31 10-7 4-2 36/52, Ex_ Tr. A & W 3
55 72 0-8 3-8 0·21 13·7 2-1 38/52, A & W I
56 510 1 ·8 3-0 0-60 12-1 3-8 36/52, Ex_ Tr. A & W 2
57 480 2-3 4-3 0·53 9-7 4-9 36/52, Ex_ Tr. A & W 3
58 846 4-7 7·4 0·63 8-4 5·5 35/52, Ex. Tr. A & W 3
59 42 2·1 9·4 0-22 16-3 2-0 39/52, A & W 1
60 960 5-2 4-8 1-08 Stillborn, 33/52 4
61 864 9-1 6-4 1·57 Stillborn, 30/52 4
62 78 1·3 5-4 0-24 14-7 2·4 39/52, A & W I
63 88 0-7 3 -I 0-22 16·4 2-0 40/52, A & W 1
64 210 3·9 6-3 0-61 11-8 3-9 38/52, Ex_ Tr. A & W 2
65 248 1·9 4·6 0-41 12-6 3·7 37/52, Ex. Tr. A & W 2
66 310 1·7 3-2 0-53 10·7 4-3 36/52, Ex. Tr. A & W 3.
t Ex_ Tr_ ~ exchange transfusion; A & W ~ alive and well.
I = mild; 2 = moderate; 3 = severe; 4 = very severe.
For comparative statistical analysis of the Rh·antibody inhibition index against other values, scored results were divided by a factor of 1,000; for example, case I,
index of 450 = 0-45_
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TABLE n. STATISTICAL EVALUATION OF ACCURACY eN PREDICTeNG
SEVERITY OF RH-HAEMOLYTIC DISEASE BEFORE BlRTH OF RH-
eNCOMPATIBLE INFANTS BY RH-ANTIBODY AND AMNIOTIC FLUID
STUDIES·
Liquor examinations are of practical significance in
determining the presence of an Rh-negative foetus.
CONCLUSIONS
From the findings reported in Parts I and 11 of this
study'·11 it is apparent that the effect of Rh antibodies on
the foetus differs in almost every Rh-immunized mother.
In some immunized pregnancies the antibody value re-
mains the same throughout pregnancy, while in others
significant changes can be anticipated which increase
foetal mortality. If variations in maternal responses to
Rh-antibody formation can be established, it must be
agreed that transplacental bleeds from the foetus to the
mother are the primary cause.
Failure to correlate raised Rh-antibody production with
the severity of Rh-haemolytic disease has led many in-
vestigators to believe that Rh-antibody titre values can-
not. be considered as true indicators of the intensity of the
disease or evidence of recent foeto-maternal bleeds. The
former opinion is well founded, because sufficient infor-
mation is available to show that although low Rh-anti-
body titre values are always associated with mild or un-
affected conditions of haemolytic disease, the reverse is
not always true for the prediction of high Rh-antibody
titres. This situation has inevitably directed investigators
away from the recognition that significant episodes of re-
immunization, regardless of their prognostic use, can be
considered as definite indicators of transplacental foetal
bleeds, and as such must present a threat to furthering the
process of immunization.
Investigations have also confirmed that external version,
abdominal paracentesis and the management of the third
stage of labour can bring about an increase in foetal red
cell transfer across the placenta, but little is known about
other defects of the placenta which cause maternal bleeds.
The findings of frequent episodes of Rh-antibody forma-
tion suggest that these are not uncommon, and this raises
the problem that an apparently satisfactory prediction of
the severity of Rhhaemolytic disease established at
30 weeks' gestation can be completely misleading 6 weeks
later.
Considering that in more than half of the Rh-im-
munized mothers significant variations in Rh-antibody re-
sponses can be anticipated to alter the prognosis of the
disease, it is not surprising that the introduction of re-
peated abdominal paracentesis emerged as an attractive
mode of management while single determinations were
often deemed unreliable. However, since the frequent
practice of abdominal paracentesis is not warranted in at
least 30% of Rh-immunized mothers (and definitely consti-
tutes a risk in furthering the intensity of immunization)
selective amniotic fluid studies based on a combination of
parameters has become more acceptable.
With the introduction of more sensitive techniques of
Rh-antibody determination; selective amniocentesis can
be accepted as a very sound complementary test for assis-
ting the obstetrician in selecting infants requiring intra-
uterine transfusions. The added advantage of this ap-
proach is the considerable assurance it affords that the risk
of furthering the intensity of Rh immunization will be










Maternal Rh-antibodY {Infant cord-blood haemoglobin value
inhibition index value Infant cord-blood bilirubin value
obtained at delivery Severity of Rh-haemolytic disease
Comparative analysis
Realizing that frequent episodes of antibody stimulation
can be expected as pregnancy progresses towards term,"
it would appear that the lack of positive correlation be-
tween bilirubin/protein ratio values and cord-blood bili-
rubin is often influenced by an increased rate of red cell
destruction seen after the amniotic fluid samples have been
taken. The possibility that raised Rh-antibody production,
induced by the disruption of foetal-placental circulation
at amniocentesis, is a contributing factor cannot of course
be ignored, and like the practice of external version" can
be considered as a factor which may further the intensity
of the disease."
It is obvious from the findings that a real measure of
confidence in the prognosis of Rh-haemolytic disease can
be attained when 2 different testing procedures are em-
ployed. However, it would also appear that even if a
statistical correlation between the testing procedures and
the severity of the disease is evident in a combined analy-
sis of many cases, the same may not necessarily be true
for some individual cases. Marked differences can oc-
casionally be anticipated due to the condition of an infant
being influenced by factors other than Rh immunization."
With the knowledge that these variations can be antici-
pated at the individual level it appears that the prognosis
of the disease should ultimately be based on the assess-
ment of a combination of parameters (previous history,
father's Rh genotype, Rh-antibody value and amniotic
fluid results) concurrent with any additional experience
gained from other statistical studies.
In an effort to help women to avoid pregnancies with a
high risk of stillbirth, prenatal counselling and exami-
nation is advocated until the mother can be assured that
the Rh-antibody value indicates that there is a fair
measure of safety for her to conceive again.
A corresponding correlation is also confirmed for the
potentiality of these 2 procedures to measure the over-all
severity of the disease. However, no real correlation could
be established between the bilirubin/protein ratio results
and the cord-blood bilirubin values, whereas a significant
association between Rh-antibody inhibition results and the
cord-blood bilirubin values is evident. Such variations
would seem to lend support to the argument that the bili-
rubin/protein ratio test (being recorded at least 4 weeks be-
fore delivery of the infant) is only able to determine the
intensity of in utero haemolysis noted at the time of
collection, and does not necessarily constitute an indi-
cative measurement of the true intensity of red cell
haemolysis to be anticipated at birth.
Highest bilirubin protein{Infant cord-blood haemoglobin value
ratio values obtained Infant cord-blood bilirubin value
between 28 and 32 Severity of Rh-haemolytic disease
weeks gestation
• See details of recorded values on 66 Rh-immunized mothers listed in Table I.
t Denotes significance at -001 level.
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SUMMARY
The present analysis has shown that the Rh-antibody inhibi-
tion test can be accepted as a reliable procedure for the ante-
natal determination of the severity of Rh-haemolytic disease of
the newborn. This was established by a comparative study of
66 Rh-immunized mothers examined by the Rh-antibody
inhibition test and liquor amnii investigations. Of particular
significance was the observation that a positive correlation
between Rh-antibody inhibition index values ;md cord-blood
bilirubin could. be established. The absence of a similar posi-
tive correlation between amniotic fluid bilirubin/protein ratio
values and cord-blood bilirubin indicates that liquor amnii
studies cannot always establish the occurrence of an increased
rate of foetal red cell destruction after the .:mniotic fluid
samples have been taken.
I wish to thank Dr R. A. Barter, Director of the Department
of Pathology, for his assistance during the course of this
investigation; Dr B. G. Grobbelaar, Director of the Natal Blood
Transfusion Service, Durban, for his contribution of maternal
serum and amniotic fluid samples from Rh-immunized mothers;
and Mr C. L. Jarvis, Computing Centre, University of Western
Australia, for carrying out the statistical evaluations men-
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CARBOHYDRATE TOLERANCE IN THE PREGNANT NATAL INDIAN*
MORRIS NOTELOVITZ, M.B., B.CH., M.D. (RAND), M.R.C.O.G., Head of the Department of Obstetrics and
Gynaecology, Addington Hospital, Durban
Recent studies have provided ample retrospective evidence
that the perinatal wastage is extremely high in the years
before the recognition of overt diabetes. Jackson' and
others'" have indicated that the foetal loss in the pre-
diabetic period varies between 10 and 50%.
The physiological changes in carbohydrate metabolism
associated with the increased demands of pregnancy are
variable when compared with the non-pregnant state.
Therefore, since the proof of an underlying diabetic dia-
thesis depends on the demonstration of abnormal carbohy-
drate tolerance, a study was instituted to evaluate 'normal'
glucose tolerance in the pregnant Natal Indian.
MATERIAL AND METHOD
The 'normal' pregnant controls who formed the basis of
this study were healthy ambulatory Natal Indians who
had attended the antenatal clinic of the Department of
Obstetrics, King Edward VIII Hospital, Durban. They
were all of the same socio-economic status. Studies of
normal carbohydrate tolerance in this group were governed
by the duration of pregnancy-measured in trimesters-
and the absence of a history suggestive of a prediabetic
state, namely, a family history of diabetes, unexplained
stillbirths and neonatal deaths, glycosuria, a history of
having had large babies (over 10 lb.) and a history of
progressive increase in birthweight of infants. Because of
the unreliability in attendance of most of our patients and
the difficulties associated with follow-up studies, it was
decided to base the assessment of glucose tolerance on the
individual testing of different patients in each of the 3 tri-
mesters of pregnancy.
To assess the significance of a prediabetic history, a
group of patients with positive histories were subjected to
similar testing. A total of 568 patients were studied. The
"Date received: 7 June 1968
patients had all been on an unrestricted diet for at least
3 days and had fasted for 8 - 12 hours overnight.
The lOO-G Glucose-Tolerance Test
The patients were given 100 G of glucose dissolved in
200 ml. of orange-flavoured water to drink. Venous blood
and urine samples were obtained in the fasting state and
2 hours after ingestion of the glucose.
Blood-Sugar Analysis
To maintain uniformity with a study of carbohydrate
metabolism in the non-pregnant Natal Indian; the blood-
sugar levels were assayed by the same technician using the
method of Herbert and Bourne.'
Urinalysis
Glucose oxidase paper was used to detect the presence
of glucose in the urine, thereby excluding false positives
from other reducing substances, and obtaining a simulta-
neous quantitative assessment of the degree of glycosuria.
RESULTS
Normal Glucose-Tolerance Curve during Pregnancy
Tbe alterations in glucose tolerance during the 3 trimes-
ters of pregnancy are reflected in Fig. 1 and are based on a
graph plotted against the mean fasting and postglucose
blood-sugar values obtained. It can be seen that although
there is little variation in the mean fasting levels during
the 3 trimesters, a definite lowering of tolerance to glucose
develops with the progression of pregnancy, being most
marked during the second trimester.
These differences were subjected to the 'f' test and were
found to be statistically significant (p < 0'01).
The normal range for fasting and the 2-hour postglucose
values were calculated by adding 2 standard deviations to
the mean. Whereas there was little difference in the fasting
values during the 3 trimesters, the 2-hour values in
